Bessemer Group’s Charles River Laboratories CRL Stock Holding History

Bessemer Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.21M	Sell	22,952 -1	-0%	-$178	0.01%	563
2026 Q1	$3.96M	Sell	22,953 -405	-2%	-$75.1K	0.01%	562
2025 Q4	$4.66M	Buy	23,358 +18,322	+364%	+$3.32M	0.01%	435
2025 Q3	$788K	Buy	5,036 +458	+10%	+$72.7K	﹤0.01%	721
2025 Q2	$694K	Sell	4,578 -2,357	-34%	-$314K	﹤0.01%	727
2025 Q1	$1.04M	Sell	6,935 -16,538	-70%	-$2.77M	﹤0.01%	682
2024 Q4	$4.33M	Sell	23,473 -3	-0%	-$578	0.01%	450
2024 Q3	$4.62M	Buy	23,476 +14,818	+171%	+$3.08M	0.01%	447
2024 Q2	$1.79M	Buy	8,658 +9	+0.1%	+$2.04K	﹤0.01%	529
2024 Q1	$2.34M	Buy	8,649 +7,095	+457%	+$1.69M	﹤0.01%	498
2023 Q4	$367K	Sell	1,554 -80	-5%	-$15.7K	﹤0.01%	909
2023 Q3	$320K	Sell	1,634 -33	-2%	-$6.78K	﹤0.01%	923
2023 Q2	$351K	Buy	1,667 +404	+32%	+$80.4K	﹤0.01%	902
2023 Q1	$255K	Sell	1,263 -61	-5%	-$13.8K	﹤0.01%	860
2022 Q4	$289K	Buy	1,324 +601	+83%	+$131K	﹤0.01%	825
2022 Q3	$142K	Sell	723 -247	-25%	-$53.3K	﹤0.01%	956
2022 Q2	$208K	Sell	970 -760	-44%	-$186K	﹤0.01%	872
2022 Q1	$491K	Sell	1,730 -260	-13%	-$80.2K	﹤0.01%	644
2021 Q4	$749K	Sell	1,990 -267	-12%	-$104K	﹤0.01%	524
2021 Q3	$931K	Buy	2,257 +8	+0.4%	+$3.32K	﹤0.01%	432
2021 Q2	$832K	Buy	2,249 +858	+62%	+$287K	﹤0.01%	453
2021 Q1	$403K	Sell	1,391 -445	-24%	-$124K	﹤0.01%	596
2020 Q4	$458K	Buy	1,836 +68	+4%	+$16.2K	﹤0.01%	550
2020 Q3	$400K	Sell	1,768 -107	-6%	-$22.2K	﹤0.01%	553
2020 Q2	$327K	Hold	1,875	–	–	﹤0.01%	1056
2020 Q1	$237K	Buy	1,875 +440	+31%	+$66K	﹤0.01%	951
2019 Q4	$219K	Hold	1,435	–	–	﹤0.01%	1058
2019 Q3	$190K	Hold	1,435	–	–	﹤0.01%	1069
2019 Q2	$204K	Sell	1,435 -89	-6%	-$12.1K	﹤0.01%	1074
2019 Q1	$221K	Sell	1,524 -155	-9%	-$20.4K	﹤0.01%	972
2018 Q4	$190K	Sell	1,679 -81	-5%	-$10.1K	﹤0.01%	992
2018 Q3	$237K	Hold	1,760	–	–	﹤0.01%	950
2018 Q2	$198K	Hold	1,760	–	–	﹤0.01%	984
2018 Q1	$188K	Hold	1,760	–	–	﹤0.01%	1014
2017 Q4	$193K	Hold	1,760	–	–	﹤0.01%	1025
2017 Q3	$190K	Hold	1,760	–	–	﹤0.01%	1071
2017 Q2	$178K	Sell	1,760 -130	-7%	-$12K	﹤0.01%	1083
2017 Q1	$170K	Sell	1,890 -43	-2%	-$3.65K	﹤0.01%	1127
2016 Q4	$147K	Buy	1,933 +43	+2%	+$3.27K	﹤0.01%	1148
2016 Q3	$158K	Hold	1,890	–	–	﹤0.01%	1026
2016 Q2	$156K	Hold	1,890	–	–	﹤0.01%	699
2016 Q1	$144K	Sell	1,890 -19,227	-91%	-$1.42M	﹤0.01%	724
2015 Q4	$1.7M	Buy	21,117 +555	+3%	+$40K	0.01%	462
2015 Q3	$1.31M	Buy	20,562 +19,227	+1,440%	+$1.38M	0.01%	510
2015 Q2	$94K	Hold	1,335	–	–	﹤0.01%	858
2015 Q1	$106K	Sell	1,335 -465	-26%	-$34.3K	﹤0.01%	814
2014 Q4	$115K	Hold	1,800	–	–	﹤0.01%	782
2014 Q3	$108K	Hold	1,800	–	–	﹤0.01%	764
2014 Q2	$96K	Hold	1,800	–	–	﹤0.01%	776
2014 Q1	$109K	Sell	1,800 -200	-10%	-$11.7K	﹤0.01%	720
2013 Q4	$107K	Hold	2,000	–	–	﹤0.01%	727
2013 Q3	$93K	Sell	2,000 -225	-10%	-$10.3K	﹤0.01%	734
2013 Q2	$91K	Buy	+2,225	New	+$95.3K	﹤0.01%	664

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Bessemer Group's CRL Position: Q2 2026 in Review

Bessemer Group reduced its Charles River Laboratories (CRL) stake by 0% in Q2 2026, selling an estimated $178 and leaving 22,952 shares worth $5.21M. The position accounts for 0.01% of the portfolio, ranked #563.

Bessemer Group first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Bessemer Group held 22,952 shares of Charles River Laboratories worth $5.21M as of Q2 2026.
Bessemer Group sold 1 Charles River Laboratories share in Q2 2026, an estimated $178.
Charles River Laboratories made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #563 holding.
Bessemer Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.